CMS recently finalized policies as part of the 2027 Medicare Advantage final rule that both enhance consumer protections and roll back changes to the Medicare Advantage program that were intended to protect consumers. These changes have gotten less attention than payment issues and changes to the star ratings system, which also affect plan payments, but…
Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn’t rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorneys say. The waiver program, run by the Department of Health and Human Services, allows physicians who…
SACRAMENTO, Calif. — In his earliest days in the governor’s office, Democrat Gavin Newsom huddled with his advisers to consider how to realize a key campaign promise: transforming a healthcare system replete with insurance company intermediaries into the nation’s first state-run single-payer model providing comprehensive coverage to all residents, similar to those in Canada and…
April has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Aledade, Humana and Zimmer Biomet named new executives. There were also layoffs at organizations including Baylor Scott & White Health Plan, Novo Nordisk and UnityPoint Health. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs…
Tennessee lawmakers recently passed a bill banning PBMs from owning pharmacies in the state, though like a similar Arkansas law, it is expected to face legal challenges if enacted. The post Will Tennessee’s PBM Bill Face the Same Fate as Arkansas’ Law? appeared first on MedCity News.
In this episode, we’re joined by Meghan Doyle, CEO of Partum Health. We discuss the company’s new partnership that offers 24/7 access to doula support at University of Chicago Medicine Family Birth Center – Hyde Park. The post MedCity FemFwd: Inside Partum Health’s Partnership with UChicago Medicine appeared first on MedCity News.
Avalayn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the company to upsize its IPO. Data from two mid-stage studies are expected in 2027. The post Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials appeared first on MedCity…
This brief examines the implications of the growing use of AI for racial and ethnic disparities in health and health care and discusses factors that can help reduce AI-related bias in health care.
This brief summarizes the “test-negative” methodology for estimating the effectiveness of influenza and COVID-19 vaccines, noting its strengths and potential limitations. This is the design is used in a CDC-led COVID-19 vaccine study that HHS decided not to publish.
Despite genuine efforts across the industry to reduce protocol complexity, the trend line hasn’t budged. The reasons are partly scientific and operational. And they’re also deeply human. The post Why Protocol Complexity Keeps Increasing – and How to Fix It appeared first on MedCity News.